Rothschild & CO Asset Management Us Inc. Jazz Pharmaceuticals PLC Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 52,249 shares of JAZZ stock, worth $7.12 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
52,249
              Previous 58,817
              
        
           11.17%
        
      
          
        Holding current value
$7.12 Million
            Previous $7.84 Million
            
        
           6.16%
        
      
          
        % of portfolio
0.13%
            Previous 0.13%
          
        Shares
	  17 transactions
	
  Others Institutions Holding JAZZ
# of Institutions
565Shares Held
62.3MCall Options Held
563KPut Options Held
79.8K- 
    
      Black Rock Inc. New York, NY6.15MShares$838 Million0.02% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA6.09MShares$830 Million0.01% of portfolio
- 
    
      Lsv Asset Management Chicago, IL2.55MShares$348 Million0.65% of portfolio
- 
    
      Capital World Investors Los Angeles, CA2.54MShares$347 Million0.04% of portfolio
- 
    
      Dimensional Fund Advisors LP Austin, TX2.54MShares$346 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.54B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...